This CORR Insights TM is a commentary on the article ''Locking Buttons Increase Fatigue Life of Locking Plates in a Segmental Bone Defect Model'' by Tompkins et al. available at
Fracture nonunions and bulk allografts are two clinically different problems with a similar common denominator: compromised biology. Because of this similarity, surgeons should seek to minimize disruption of the soft tissue envelope and to use biomechanically sound principles of fixation when treating either condition. Absolute stability with interfragmentary compression should be the goal in simple fracture patterns, whereas relative stability and minimal soft tissue stripping are key in fractures with severe comminution. Bulk allografts pose a more challenging problem as appropriate stability usually can be achieved, but dead tissue has a limited capacity to heal, and without an osseous union, fixation constructs inevitably will fail regardless of implant strength. In either setting, medical comorbidities such as diabetes, tobacco use, osteoporosis, radiation damage, and chemotherapy, further disrupt the biology and continue to trouble surgeons and patients alike. In these difficult scenarios, where impaired biology may lead to delayed healing, a simple method to prolong implant lifespan, as outlined in the article by Tompkins et al., gives the treating surgeon another basic tool in the armamentarium.
Where Do We Need to Go?
We do not know how or whether future implant technology will improve on existing implants. Current technology provides the treating surgeon with various options to attain the appropriate mechanobiologic environment. We need more complete understanding of the ideal amount of construct stiffness; the goal is sufficient strain distribution across the fracture to promote healing, but not so much stiffness that healing is inhibited. Future endeavors also should concentrate on enhancing the local biological environment. If it could be shown that increasing the frequency of loading cycles within a certain time (thus increasing the number of cycles) is a strategy to enhance healing, the data and technique gained from this paper would be especially useful. However, creating an osteoinductive environment through a combination of systemic and local treatments will likely yield the highest return; for The authors certify that they, or a member of their immediate families, have no funding or commercial associations (eg, consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article. All ICMJE Conflict of Interest Forms for authors and Clinical Orthopaedics and Related Research editors and board members are on file with the publication and can be viewed on request. example, knowing how to appropriately load fractures after fixation to stimulate healing (ie, when to let the patient bear weight, and how much), developing osteoinductive technologies, educating physicians on best approaches, and optimizing the management of medical comorbidities.
How Do We Get There?
Many answers will come from the basic science laboratories. Developing technologies to promote reliable differentiation of mesenchymal stem cells into osteogenic cells, and research into osteoinductive drugs (similar to BMP, pulsed parathyroid hormone, etc) seem promising. In addition, drug delivery systems that minimize host systemic exposure will be important. Studying the resultant histopathological responses in conjunction with biomechanical studies in animal models, followed by welldesigned clinical studies where new technologies and rehabilitation protocols have evolved, will be crucial. Many such ideas are in the pipeline, and future clinicianscientists who have the ability to bring them from the bench-to-bedside will be essential for continued progress and success.
